Nnmc cepheid molecular diagnostic testing supplies and reagents

Ended Purchase Order Awarded Last action

Contract number
75H71025P01151
Awardee
Awarding agency
Obligated
$1,250,000

Award facts

Opportunity
Contract value 100% obligated
$1,250,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Sunnyvale, CA 94089, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · Nnmc cepheid molecular diagnostic testing supplies and reagents - MOD 1 - add funds $750,000
Original award $500,000

About this award

The Indian Health Service awarded a $1.25 million firm fixed-price purchase order to Cepheid Inc. for molecular diagnostic testing supplies and reagents on September 17, 2025, with an ultimate completion date of September 15, 2026. The procurement originated from a Special Notice published on August 14, 2025, announcing the agency's intent to negotiate a sole-source award with Cepheid for laboratory test kits and reagents compatible with the Cepheid Infinity Analyzer platform, specifically to support diagnostic testing operations at the Northern Navajo Medical Center in Shiprock, New Mexico, and Four Corners Regional Health Center in Teec Nos Pos, Arizona, within the Navajo Area, Shiprock Service Unit. The award includes a modification adding funds to the initial purchase order. No small business set-aside designation was used for this contract, and the place of performance is Cepheid's headquarters in Sunnyvale, California.

Cepheid Inc., a manufacturer of advanced molecular diagnostic systems and reagents headquartered in Sunnyvale, California, has established itself as a primary federal supplier of diagnostic solutions across multiple federal healthcare agencies, including extensive relationships with the Department of Veterans Affairs, Defense Health Agency, Defense Logistics Agency, and the U.S. Coast Guard. The company's core competencies include providing rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, tuberculosis, and sexually transmitted infections through its GeneXpert diagnostic platform. This procurement reflects the Indian Health Service's continued reliance on Cepheid as a trusted supplier of validated diagnostic supplies that conform to Clinical Laboratory Improvement Amendments (CLIA) laboratory standards for tribal healthcare operations.

Quick answers

Who was awarded contract 75H71025P01151?

75H71025P01151 was awarded to Cepheid by Indian Health Service (Department of Health and Human Services) on September 17, 2025.

How much is contract 75H71025P01151 worth?

The government has obligated $1,250,000 on 75H71025P01151.

Was contract 75H71025P01151 competed?

The extent of competition for 75H71025P01151 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award